Cognigenics is developing iRNAi™, a precise, non-invasive, intranasal RNA interference platform that delivers programmable therapeutics directly to key areas of the brain to modulate the neural circuits underlying mood, memory, and cognition—supporting lasting brain health and cognitive function across the lifespan
Cognigenics is developing iRNAi™, a precise, non-invasive, intranasal RNA interference platform that delivers programmable therapeutics directly to key areas of the brain to modulate the neural circuits underlying mood, memory, and cognition—supporting lasting brain health and cognitive function across the lifespan.